NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – The hope of finding a way to quickly measure carboxyhemoglobin levels in suspected carbon monoxide poisoning is still unfulfilled, it seems. The Rad-57…
NEW YORK (Reuters Health) – Among women treated for endometrial hyperplasia, regression rates appear to be better with the levonorgestrel-releasing intrauterine system than with oral progestogen treatment, according…
NEW YORK (Reuters Health) – Percutaneous revascularization of the left main coronary artery can be performed via the transradial approach, with success rates similar to transfemoral access, according…
NEW YORK (Reuters Health) – In terms of efficacy and safety, low-molecular weight heparin is better than unfractionated heparin in the treatment of patients presenting with cerebral venous…
NEW YORK (Reuters Health) – Patients with atrial fibrillation undergoing pulmonary vein isolation by radiofrequency catheter ablation are less likely to have immediate recurrence of AF if they’re…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that anticoagulation may not need to be interrupted in patients undergoing elective coronary angiography. However, the quality of…
NEW YORK (Reuters Health) – Patients with age-related macular degeneration treated with the anti-VEGF monoclonal antibodies bevacizumab and ranibizumab do not have any higher rates of mortality, MI…
